Annual FCF
-$128.51 M
-$57.49 M-80.95%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual free cash flow is -$128.51 million, with the most recent change of -$57.49 million (-80.95%) on December 31, 2023.
- During the last 3 years, AVDL annual FCF has fallen by -$79.68 million (-163.17%).
- AVDL annual FCF is now -255.46% below its all-time high of $82.66 million, reached on December 31, 2015.
Performance
AVDL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$6.89 M
+$11.30 M+62.11%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly free cash flow is -$6.89 million, with the most recent change of +$11.30 million (+62.11%) on September 30, 2024.
- Over the past year, AVDL quarterly FCF has increased by +$21.14 million (+75.42%).
- AVDL quarterly FCF is now -126.66% below its all-time high of $25.85 million, reached on December 31, 2015.
Performance
AVDL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$82.81 M
+$31.34 M+27.45%
September 30, 2024
Summary
- As of February 20, 2025, AVDL TTM free cash flow is -$82.81 million, with the most recent change of +$31.34 million (+27.45%) on September 30, 2024.
- Over the past year, AVDL TTM FCF has increased by +$45.70 million (+35.56%).
- AVDL TTM FCF is now -200.18% below its all-time high of $82.66 million, reached on December 31, 2015.
Performance
AVDL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AVDL Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -81.0% | +75.4% | +35.6% |
| 3 y3 years | -163.2% | +78.5% | +2.7% |
| 5 y5 years | -24.9% | +78.5% | +2.7% |
AVDL Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.0% | at low | at high | +82.0% | -23.2% | +35.6% |
| 5 y | 5-year | -235.1% | at low | at high | +82.0% | -188.0% | +35.6% |
| alltime | all time | -255.5% | at low | -126.7% | +87.6% | -200.2% | +35.6% |
Avadel Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.89 M(-62.1%) | -$82.81 M(-27.5%) |
| Jun 2024 | - | -$18.19 M(-38.8%) | -$114.14 M(-10.8%) |
| Mar 2024 | - | -$29.70 M(+6.0%) | -$127.98 M(-0.4%) |
| Dec 2023 | -$128.51 M(+81.0%) | -$28.03 M(-26.7%) | -$128.51 M(+10.9%) |
| Sep 2023 | - | -$38.23 M(+19.4%) | -$115.85 M(+36.1%) |
| Jun 2023 | - | -$32.02 M(+5.9%) | -$85.14 M(+26.7%) |
| Mar 2023 | - | -$30.23 M(+96.8%) | -$67.21 M(-5.4%) |
| Dec 2022 | -$71.02 M(-8.2%) | -$15.37 M(+104.4%) | -$71.02 M(-9.1%) |
| Sep 2022 | - | -$7.52 M(-46.6%) | -$78.16 M(-14.9%) |
| Jun 2022 | - | -$14.09 M(-58.6%) | -$91.88 M(+4.5%) |
| Mar 2022 | - | -$34.05 M(+51.3%) | -$87.94 M(+13.7%) |
| Dec 2021 | -$77.34 M(+58.4%) | -$22.51 M(+6.0%) | -$77.34 M(+4.5%) |
| Sep 2021 | - | -$21.24 M(+109.2%) | -$74.02 M(+17.5%) |
| Jun 2021 | - | -$10.15 M(-56.7%) | -$63.01 M(+3.9%) |
| Mar 2021 | - | -$23.44 M(+22.1%) | -$60.63 M(+24.2%) |
| Dec 2020 | -$48.83 M(+27.3%) | -$19.19 M(+87.7%) | -$48.83 M(+28.9%) |
| Sep 2020 | - | -$10.22 M(+31.4%) | -$37.90 M(+8.0%) |
| Jun 2020 | - | -$7.78 M(-33.1%) | -$35.09 M(+22.0%) |
| Mar 2020 | - | -$11.64 M(+41.0%) | -$28.75 M(-25.0%) |
| Dec 2019 | -$38.35 M(-62.7%) | -$8.25 M(+11.2%) | -$38.35 M(-29.8%) |
| Sep 2019 | - | -$7.42 M(+413.1%) | -$54.64 M(-19.1%) |
| Jun 2019 | - | -$1.45 M(-93.2%) | -$67.53 M(-36.3%) |
| Mar 2019 | - | -$21.24 M(-13.5%) | -$106.08 M(+3.1%) |
| Dec 2018 | -$102.89 M(+177.8%) | -$24.54 M(+20.8%) | -$102.89 M(+10.4%) |
| Sep 2018 | - | -$20.32 M(-49.2%) | -$93.20 M(-27.4%) |
| Jun 2018 | - | -$39.99 M(+121.6%) | -$128.30 M(+60.2%) |
| Mar 2018 | - | -$18.05 M(+21.6%) | -$80.06 M(+116.2%) |
| Dec 2017 | -$37.04 M(-309.3%) | -$14.85 M(-73.2%) | -$37.04 M(+152.8%) |
| Sep 2017 | - | -$55.41 M(-772.4%) | -$14.65 M(-141.0%) |
| Jun 2017 | - | $8.24 M(-67.0%) | $35.75 M(+57.1%) |
| Mar 2017 | - | $24.97 M(+231.2%) | $22.77 M(+28.6%) |
| Dec 2016 | $17.70 M(-78.6%) | $7.54 M(-250.8%) | $17.70 M(-50.8%) |
| Sep 2016 | - | -$5.00 M(+5.3%) | $36.01 M(-39.2%) |
| Jun 2016 | - | -$4.75 M(-123.8%) | $59.18 M(-23.7%) |
| Mar 2016 | - | $19.91 M(-23.0%) | $77.53 M(-6.2%) |
| Dec 2015 | $82.66 M(-769.6%) | $25.85 M(+42.2%) | $82.66 M(+64.7%) |
| Sep 2015 | - | $18.18 M(+33.6%) | $50.18 M(+44.2%) |
| Jun 2015 | - | $13.60 M(-45.7%) | $34.81 M(+124.7%) |
| Mar 2015 | - | $25.04 M(-477.4%) | $15.49 M(-225.5%) |
| Dec 2014 | -$12.35 M(-43.1%) | -$6.63 M(-336.5%) | -$12.35 M(-5.0%) |
| Sep 2014 | - | $2.81 M(-149.1%) | -$12.99 M(-20.0%) |
| Jun 2014 | - | -$5.72 M(+104.4%) | -$16.24 M(-1.5%) |
| Mar 2014 | - | -$2.80 M(-61.6%) | -$16.48 M(-24.1%) |
| Dec 2013 | -$21.70 M(-10.3%) | -$7.28 M(+1528.9%) | -$21.70 M(+3.8%) |
| Sep 2013 | - | -$447.00 K(-92.5%) | -$20.91 M(-20.8%) |
| Jun 2013 | - | -$5.96 M(-25.7%) | -$26.40 M(-3.3%) |
| Mar 2013 | - | -$8.02 M(+23.7%) | -$27.31 M(+12.8%) |
| Dec 2012 | -$24.21 M | -$6.48 M(+9.2%) | -$24.21 M(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$5.94 M(-13.5%) | -$21.76 M(+21.2%) |
| Jun 2012 | - | -$6.86 M(+39.5%) | -$17.95 M(+50.7%) |
| Mar 2012 | - | -$4.92 M(+21.8%) | -$11.92 M(-2.5%) |
| Dec 2011 | -$12.23 M(+35.0%) | -$4.04 M(+89.7%) | -$12.23 M(+43.1%) |
| Sep 2011 | - | -$2.13 M(+158.2%) | -$8.54 M(-27.7%) |
| Jun 2011 | - | -$825.00 K(-84.2%) | -$11.82 M(+16.6%) |
| Mar 2011 | - | -$5.23 M(+1361.2%) | -$10.13 M(+11.9%) |
| Dec 2010 | -$9.06 M(-240.9%) | -$358.00 K(-93.4%) | -$9.06 M(-37.3%) |
| Sep 2010 | - | -$5.41 M(-728.0%) | -$14.45 M(+85.7%) |
| Jun 2010 | - | $861.00 K(-120.7%) | -$7.78 M(+47.8%) |
| Mar 2010 | - | -$4.15 M(-27.8%) | -$5.26 M(-181.9%) |
| Dec 2009 | $6.42 M(-158.2%) | -$5.75 M(-555.5%) | $6.42 M(-31.7%) |
| Sep 2009 | - | $1.26 M(-62.6%) | $9.41 M(-0.6%) |
| Jun 2009 | - | $3.38 M(-55.2%) | $9.46 M(+778.7%) |
| Mar 2009 | - | $7.54 M(-372.1%) | $1.08 M(-109.8%) |
| Dec 2008 | -$11.03 M(-63.8%) | -$2.77 M(-310.0%) | -$11.03 M(+10.6%) |
| Sep 2008 | - | $1.32 M(-126.3%) | -$9.97 M(-49.2%) |
| Jun 2008 | - | -$5.01 M(+9.5%) | -$19.62 M(-19.6%) |
| Mar 2008 | - | -$4.57 M(+167.5%) | -$24.40 M(-20.0%) |
| Dec 2007 | -$30.51 M(-15.8%) | -$1.71 M(-79.5%) | -$30.51 M(-12.4%) |
| Sep 2007 | - | -$8.34 M(-14.8%) | -$34.84 M(+0.6%) |
| Jun 2007 | - | -$9.79 M(-8.4%) | -$34.65 M(-3.2%) |
| Mar 2007 | - | -$10.68 M(+77.1%) | -$35.81 M(-1.1%) |
| Dec 2006 | -$36.22 M(+17.9%) | -$6.03 M(-25.9%) | -$36.22 M(-15.8%) |
| Sep 2006 | - | -$8.14 M(-25.6%) | -$43.02 M(+0.9%) |
| Jun 2006 | - | -$10.95 M(-1.3%) | -$42.65 M(+19.1%) |
| Mar 2006 | - | -$11.10 M(-13.5%) | -$35.81 M(+16.6%) |
| Dec 2005 | -$30.71 M(+70.8%) | -$12.83 M(+65.1%) | -$30.71 M(+40.5%) |
| Sep 2005 | - | -$7.77 M(+89.4%) | -$21.86 M(-1.4%) |
| Jun 2005 | - | -$4.11 M(-31.6%) | -$22.17 M(-4.0%) |
| Mar 2005 | - | -$6.00 M(+50.9%) | -$23.09 M(+28.4%) |
| Dec 2004 | -$17.99 M(-308.3%) | -$3.98 M(-50.8%) | -$17.99 M(>+9900.0%) |
| Sep 2004 | - | -$8.08 M(+60.6%) | -$135.00 K(-101.7%) |
| Jun 2004 | - | -$5.03 M(+461.5%) | $7.95 M(-11.3%) |
| Mar 2004 | - | -$896.00 K(-106.5%) | $8.96 M(+3.8%) |
| Dec 2003 | $8.63 M(+17.7%) | $13.87 M(>+9900.0%) | $8.63 M(-264.8%) |
| Sep 2003 | - | $0.00(-100.0%) | -$5.24 M(0.0%) |
| Jun 2003 | - | -$4.02 M(+228.1%) | -$5.24 M(+328.1%) |
| Mar 2003 | - | -$1.22 M(+53.0%) | -$1.22 M(+53.0%) |
| Dec 2002 | $7.34 M(-285.2%) | - | - |
| Dec 2001 | -$3.96 M(-37.7%) | - | - |
| Dec 2000 | -$6.36 M(+29.5%) | - | - |
| Dec 1999 | -$4.91 M(-47.3%) | - | - |
| Dec 1998 | -$9.32 M(-11.2%) | - | - |
| Mar 1998 | - | -$800.00 K(-366.7%) | -$800.00 K(-366.7%) |
| Dec 1997 | -$10.50 M(+84.2%) | - | - |
| Dec 1996 | -$5.70 M | - | - |
| Mar 1996 | - | $300.00 K | $300.00 K |
FAQ
- What is Avadel Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual FCF year-on-year change?
- What is Avadel Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly FCF year-on-year change?
- What is Avadel Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals TTM FCF year-on-year change?
What is Avadel Pharmaceuticals annual free cash flow?
The current annual FCF of AVDL is -$128.51 M
What is the all time high annual FCF for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual free cash flow is $82.66 M
What is Avadel Pharmaceuticals annual FCF year-on-year change?
Over the past year, AVDL annual free cash flow has changed by -$57.49 M (-80.95%)
What is Avadel Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AVDL is -$6.89 M
What is the all time high quarterly FCF for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly free cash flow is $25.85 M
What is Avadel Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AVDL quarterly free cash flow has changed by +$21.14 M (+75.42%)
What is Avadel Pharmaceuticals TTM free cash flow?
The current TTM FCF of AVDL is -$82.81 M
What is the all time high TTM FCF for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM free cash flow is $82.66 M
What is Avadel Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AVDL TTM free cash flow has changed by +$45.70 M (+35.56%)